Anti-Infectives / Critical Care

AugmitOS 625

Amoxycillin (500mg) + Clavulanic Acid (125mg)

AugmitOS 625 pack
New LaunchRx Only

About this product

Trusted broad-spectrum oral antibiotic coverage for sinusitis, otitis media, respiratory infections, skin/soft-tissue infections, including bite wounds, and susceptible UTIs.

Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg)
AugmitOS 625 composition as printed on the pack
As printed on the pack
Therapy Area
Anti-Infectives / Critical Care
Formulation
Tablet
Pack
Strip of 10
Storage
≤ 25°C

Overview

AugmitOS 625 combines amoxycillin with clavulanic acid, restoring effectiveness against many common beta-lactamase-producing bacteria. It is a versatile, well-recognised choice across respiratory, ENT, dental, skin, and bite-wound infections.

Indications

Acute bacterial sinusitis and otitis media
Community-acquired pneumonia and bronchitis exacerbations
Skin / soft-tissue infections, including bite wounds
Dental and odontogenic infections
Urinary tract infections due to susceptible organisms
Rx only. For use under medical supervision. Intended for healthcare professionals in India.

Partner With Schemic Concepts

Engineer better health outcomes with precision-driven pharmaceuticals

Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it

Partner With Us